Erratum: Anti-Granulocyte-Macrophage Colony-Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial.

Authors
Journal	American journal of respiratory and critical care medicine (Am J Respir Crit Care Med) Vol. 206 Issue 6 Pg. 801 (Sep 15 2022) ISSN: 1535-4970 [Electronic] United States
PMID	36112778 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!